Alexander Sedaghat

Showing 1-7 of 7 articles

Outcomes of myocardial fibrosis in patients undergoing transcatheter aortic valve replacement

Sugiura A, Weber M, von Depka A, Tabata N, Shamekhi J, Al-Kassou B, Nickenig G, Werner N, Sinning J, Sedaghat A

March 20, 2020 | 10.4244/EIJ-D-19-00641

Interventions for valvular disease

Impact of implant depth on hydrodynamic function of the ALLEGRA bioprosthesis in valve-in-valve interventions

Sathananthan J, Fraser R, Kütting M, Hensey M, Landes U, Alkhodair A, Sedaghat A, Blanke P, Toggweiler S, Leipsic J, Søndergaard L, Wood D, Webb J

February 7, 2020 | 10.4244/EIJ-D-19-00782

Interventions for valvular disease

In vitro hydrodynamic and acute clinical performance of a novel self-expanding transcatheter heart valve in various surgical bioprostheses

Sedaghat A, Sinning J, Werner N, Nickenig G, Conradi L, Toggweiler S, Schäfer U

April 20, 2018 | 10.4244/EIJ-D-17-00844

Interventions for valvular disease

Balloon post-dilation and valve-in-valve implantation for the reduction of paravalvular leakage with use of the self-expanding CoreValve prosthesis

Stundl A, Rademacher M-C, Descoups C, Weber M, Sedaghat A, Grube M, Hammerstingl C, Mellert F, Vasa-Nicotera M, Welz A, Grube E, Werner N, Nickenig G, Sinning J

February 19, 2016 | 10.4244/EIJY15M11_04

Use of a balloon-expandable transfemoral sheath in a TAVI cohort with complex access site - a propensity score matched analysis

Sedaghat A, von Dobbeler C, Sontag B, Sinning J, Fimmers R, Mellert F, Schiller W, Welz A, Grube E, Nickenig G, Hauptmann K-E, Werner N

October 20, 2015 | 10.4244/EIJY15M01_10

Doppler-based renal resistance index for the detection of acute kidney injury and the non-invasive evaluation of paravalvular aortic regurgitation after transcatheter aortic valve implantation

Sinning J, Adenauer V, Scheer A, Cachiguango S, Ghanem A, Hammerstingl C, Sedaghat A, Müller C, Vasa-Nicotera M, Grube E, Nickenig G, Werner N

March 20, 2014 | 10.4244/EIJV9I11A221

Decrease of pulmonary hypertension impacts on prognosis after transcatheter aortic valve replacement

Sinning J, Hammerstingl C, Chin D, Ghanem A, Schueler R, Sedaghat A, Bence J, Spyt T, Werner N, Kovac J, Grube E, Nickenig G, Vasa-Nicotera M

January 20, 2014 | 10.4244/EIJV9I9A177

1

Latest news

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

Don’t Miss #EIJOnAir 2nd Edition!

Elective cardiac invasive procedures during the COVID-19 outbreak

MitraClip for a range of LV dysfunction and secondary MR

Stamatios Lerakis et al.

Thrombolysis in ST-elevation myocardial infarction is not dead

Petr Kala et al.

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

Valvular disease